Over the years bone densitometers have known to trend downwards. With that being said, can bone densitometers still be economically viable for users?
Over the last several years, it has been observed that bone density reimbursements have dropped significantly from what they once were. Since the decline has affected many medical practitioners, many healthcare providers have been selling off their bone densitometers in attempt to pursue other imaging modalities.
However, in spite of the recent decline, professional bone densitometer vendors have stated that they are still doing well despite the current rates of reimbursements.
So how come some providers have success in bone densitometers as opposed to the decline?
The primary factor to consider is management.
Having a steady clientele of relevant patients is essential for practitioners to set themselves up for success. However, the most important thing to remember is that proper management is what could generate a steady volume of patients for different medical facilities.
When it comes to post-menopausal women who have been diagnosed with osteoporosis, having a bone scan every year is essential. Monitoring the frequency of the relevant patients who are eligible to undergo a bone study could help with better management of clients. That way the bone density providers can increase the likelihood of retaining patients.
In turn, the retention can help assure a volume of patients that would be able to negate the reimbursements while allowing the bone densitometer to remain a constant source of revenue for medical facilities.
If your medical facility is looking to obtain a bone density machine for sale, Amber USA might be just the place for you.
Amber USA is a long-standing firm known for issuing high-quality used and refurbished medical imaging equipment to ensure medical facilities are able to provide the best service to their patients.